Harvard Bioscience to Discuss Upcoming Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) is set to release its financial results for the first quarter of 2025 on May 12, 2025. The company plans to publish these results before the market opens, providing insights into its performance and future outlook.
Conference Call Scheduled for Stakeholders
To facilitate discussions regarding these financial results, Harvard Bioscience will hold an earnings conference call at 8:00 a.m. Eastern Time. This is a valuable opportunity for stakeholders and investors to gain clarity on the company's financial health and strategic direction.
How to Participate
Those who wish to be part of the call and ask questions must register in advance. Upon registration, participants will receive the necessary dial-in numbers and a unique PIN to join the conversation. Engaging during the call helps keep communication between the company and its investors active and transparent.
Webcast for Broader Audience
For individuals preferring an audio-only presentation, Harvard Bioscience offers a webcast option. Interested participants can access this via the investor section on the company's website, ensuring that external as well as internal stakeholders are informed about the firm’s financial stance.
Access to Financial Materials
During the conference call, financial materials, including the earnings release and detailed slide presentation, will be made available. Stakeholders are encouraged to review these materials to better understand the company’s operational performance and strategies.
About Harvard Bioscience
Harvard Bioscience, Inc. has established itself as a leading innovator in life science technologies. The company specializes in developing, manufacturing, and selling a diverse range of products and services that empower significant advances across various life science applications. Its customer base includes prestigious academic institutions, government laboratories, and top pharmaceutical and biotechnology firms around the world.
Global Reach and Operations
With a strong presence in North America, Europe, and Asia, Harvard Bioscience utilizes a mix of direct sales and distribution channels to serve its global clientele. This broad operational footprint allows the company to meet diverse needs in preclinical testing, bioproduction, and therapy discovery effectively.
Contact Information
For additional inquiries or information, interested parties can reach out to Jennifer Cote, the Chief Financial Officer at Harvard Bioscience, via phone at (508) 893-3120 or by email at investors@harvardbioscience.com.
Frequently Asked Questions
1. When will Harvard Bioscience release its financial results?
The financial results for the first quarter of 2025 will be announced on May 12, 2025.
2. How can I join the earnings conference call?
To join the call, participants need to register in advance to receive the dial-in information and PIN.
3. Is there a way to listen to the webcast of the call?
Yes, the audio-only webcast will be available on the investor section of Harvard Bioscience’s website.
4. What materials will be shared during the conference call?
Financial information including the earnings release and presentation slides will be shared during the call.
5. Who can I contact for more information?
Jennifer Cote, Chief Financial Officer, can be contacted for any additional inquiries regarding the company.
